1. | stangboy0610 | |
2. | pa838 | |
3. | smithat9474 | |
4. | ryder69398 | |
5. | vathosai |
1. | stangboy0610 | |
2. | pa838 | |
3. | smithat9474 | |
4. | ryder69398 | |
5. | vathosai |
1. | ryder69398 03/05/2018 Dermira Inc (DERM): Hit Me Baby One More Time |
2. | stangboy0610 06/29/2018 Dermira (DERM) Stock Will Not Climb Much From Here, Says Analyst |
3. | pa838 03/05/2018 Dead on arrival |
4. | vathosai 06/29/2018 Is Dermira (DERM) Poised to Win Big With Hyperhidrosis' Treatment? |
5. | stangboy0610 02/26/2018 Dermira Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update |
6. | smithat9474 02/22/2018 Misses EPS loss estimates by $0.12. Slightly beats on revenues. |
7. | smithat9474 02/01/2018 Dermira Initiates Phase 2b Dose-Ranging Study Evaluating Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis |
8. | pa838 03/05/2018 Dermira’s Two Phase 3 Trials Evaluating Olumacostat Glasaretil in Patients with Acne Vulgaris Did Not Meet… |